Jennifer Price, MD

CTSI Profile Photo

Jennifer Price, MD

User Profile Name
Associate Professor, School of Medicine
CTSI Profile Title
User Profile Email
Visit CTSI Profile

Biography

Dr. Jennifer Cohen Price is an Assistant Clinical Professor of Medicine and hepatologist, specializing in treating patients needing liver transplants. Her research interests include liver disease in HIV infection, the natural history and treatment of viral hepatitis, and nonalcoholic fatty liver disease.

User Profile Bio

Displaying 51 - 75 of 76

  1. Price JC, Dodge JL, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski S, Tien PC. Controlled attenuation parameter and magnetic resonance spectroscopy-measured liver steatosis are discordant in obese HIV-infected adults. AIDS. 2017 09 24; 31(15):2119-2125.
    http://www.ncbi.nlm.nih.gov/pubmed/28042242
  2. Jennifer Price, Jennifer Dodge, Yifei Ma, Rebecca Scherzer, Natalie Korn, Kyle Tillinghast, Marion Peters, Sue Noworolski, Phyllis Tien. Correlation of Controlled Attenuation Parameter and Magnetic Resonance Spectroscopy Measurements of Hepatic Steatosis in HIV-positive Adults. The American Journal of Gastroenterology. 2016 Oct 1; 111:s371.
  3. Price JC, Wang R, Seaberg EC, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus. Open Forum Infect Dis. 2017; 4(3):ofx153.
    http://www.ncbi.nlm.nih.gov/pubmed/27378445
  4. Price JC, Tien PC. Reply. Hepatology. 2017 08; 66(2):674-675.
    http://www.ncbi.nlm.nih.gov/pubmed/26945179
  5. Price JC, Ma Y, Scherzer R, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Human immunodeficiency virus-infected and uninfected adults with non-genotype 3 hepatitis C virus have less hepatic steatosis than adults with neither infection. Hepatology. 2017 03; 65(3):853-863.
    http://www.ncbi.nlm.nih.gov/pubmed/25944240
  6. Reid M, Ma Y, Scherzer R, Price JC, French AL, Plankey MW, Grunfeld C, Tien PC. Higher CD163 levels are associated with insulin resistance in hepatitis C virus-infected and HIV-infected adults. AIDS. 2017 01 28; 31(3):385-393.
    http://www.ncbi.nlm.nih.gov/pubmed/25604355
  7. Kardashian A, Ma Y, Scherzer R, Price JC, Sarkar M, Korn N, Tillinghast K, Peters MG, Noworolski SM, Tien PC. Sex differences in the association of HIV infection with hepatic steatosis. AIDS. 2017 01 28; 31(3):365-373.
    http://www.ncbi.nlm.nih.gov/pubmed/25183500
  8. Park L, Mone A, Price JC, Tzimas D, Hirsh J, Poles MA, Malter L, Chen LA. Perceptions of fecal microbiota transplantation for Clostridium difficile infection: factors that predict acceptance. Ann Gastroenterol. 2017; 30(1):83-88.
    http://www.ncbi.nlm.nih.gov/pubmed/25177365
  9. Jennifer Price, Jennifer Dodge, Yifei Ma, Rebecca Scherzer, Natalie Korn, Kyle Tillinghast, Marion Peters, Sue Noworolski, Phyllis Tien. Correlation of Controlled Attenuation Parameter and Magnetic Resonance Spectroscopy Measurements of Hepatic Steatosis in HIV-positive Adults. The American Journal of Gastroenterology. 2016 Oct 1; 111:s371.
    http://www.ncbi.nlm.nih.gov/pubmed/25102983
  10. Konerman MA, Price JC, Campbell CY, Eluri S, Gurakar A, Hamilton J, Li Z. Pre-Liver Transplant Transthoracic Echocardiogram Findings and 6-Month Post-Transplant Outcomes: A Case-Control Analysis. Ann Transplant. 2016 Jul 05; 21:416-27.
    http://www.ncbi.nlm.nih.gov/pubmed/24928903
  11. Price JC, Seaberg EC, Phair JP, Witt MD, Koletar SL, Thio CL. Brief Report: Highly Active Antiretroviral Therapy Mitigates Liver Disease in HIV Infection. . 2016 07 01; 72(3):319-23.
    http://www.ncbi.nlm.nih.gov/pubmed/24642579
  12. Kardashian AA, Price JC. Hepatitis C virus-HIV-coinfected patients and liver transplantation. Curr Opin Organ Transplant. 2015 Jun; 20(3):276-85.
    http://www.ncbi.nlm.nih.gov/pubmed/24563276
  13. Price JC, Terrault NA. Treatment of hepatitis C in liver transplant patients: interferon out, direct antiviral combos in. Liver Transpl. 2015 Apr; 21(4):423-34.
    http://www.ncbi.nlm.nih.gov/pubmed/24531556
  14. Jennifer C. Price. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatology Reports. 2013 Dec 1; 12(4):227-235.
  15. Jennifer Price, Valentina Shvachko, Rosemary Murphy, Michele M. Manos. Characteristics of HCV Direct Acting Antiviral Treatment Initiators in a Large Integrated Care Setting. The American Journal of Gastroenterology. 2013 Oct 1; 108:s151.
  16. Jennifer Price, Eric Seaberg, Anand Mehta, Sheila Badri, Mallory Witt, Kristin D'Acunto, Chloe Thio. Non-invasive Liver Fibrosis Markers Are Associated with Liver-Related Death in the Multicenter AIDS Cohort Study. The American Journal of Gastroenterology. 2013 Oct 1; 108:s153.
  17. Price JC, Terrault NA. Sofosbuvir and ribavirin use in wait-listed patients with hepatitis C should be selective. Liver Int. 2015 Jan; 35(1):7-8.
    http://www.ncbi.nlm.nih.gov/pubmed/23792504
  18. Price JC. Prevention and Treatment of Recurrent Hepatitis C after Liver Transplantation. Current Hepatitis Reports. 2013; 12(4):227-235.
  19. Konerman MA, Price J, Torres D, Li Z. Randomized, controlled pilot study comparing large-volume paracentesis using wall suction and traditional glass vacuum bottle methods. Therap Adv Gastroenterol. 2014 Sep; 7(5):184-92.
    http://www.ncbi.nlm.nih.gov/pubmed/23107782
  20. Price JC, Murphy RC, Shvachko VA, Pauly MP, Manos MM. Effectiveness of telaprevir and boceprevir triple therapy for patients with hepatitis C virus infection in a large integrated care setting. Dig Dis Sci. 2014 Dec; 59(12):3043-52.
    http://www.ncbi.nlm.nih.gov/pubmed/22291196
  21. Chen T, Hubbard A, Murtazina R, Price J, Yang J, Cha B, Sarker R, Donowitz M. Myosin VI mediates the movement of NHE3 down the microvillus in intestinal epithelial cells. J Cell Sci. 2014 Aug 15; 127(Pt 16):3535-45.
    http://www.ncbi.nlm.nih.gov/pubmed/20851211
  22. Price JC, Seaberg EC, Latanich R, Budoff MJ, Kingsley LA, Palella FJ, Witt MD, Post WS, Thio CL. Risk factors for fatty liver in the Multicenter AIDS Cohort Study. Am J Gastroenterol. 2014 May; 109(5):695-704.
    http://www.ncbi.nlm.nih.gov/pubmed/20437743
  23. Price J and Li Z. . Hepatitis B- Recent Developments in Therapy. European Gastroenterology & Hepatology Review. 2009; 5(1):38-42.
  24. Jodorkovsky D, Price JC, Kim B, Dhalla S, Stein EM, Clarke JO. Multichannel intraluminal impedance-pH testing is clinically useful in the management of patients with gastroesophageal reflux symptoms. Dig Dis Sci. 2014 Aug; 59(8):1817-22.
    http://www.ncbi.nlm.nih.gov/pubmed/16808738
  25. Price J. An update on hepatitis B, D, and E viruses. Top Antivir Med. 2014 Jan; 21(5):157-63.
    http://www.ncbi.nlm.nih.gov/pubmed/16117754